We are live on
!
Find out more
CYTH
Cyclo Therapeutics, Inc. Common Stock
CYTH
CYTH
Delisted
CYTH was delisted on the 25th of March, 2025.
23 hedge funds and large institutions have $2.1M invested in Cyclo Therapeutics, Inc. Common Stock in 2023 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 8 increasing their positions, 3 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
207% more capital invested
Capital invested by funds: $683K → $2.1M (+$1.42M)
200% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 3
167% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 3
35% more funds holding
Funds holding: 17 → 23 (+6)
Holders
23
Holders Change
+6
Holders Change %
+35.29%
% of All Funds
0.34%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.03%
New
9
Increased
8
Reduced
3
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
| 1 |
VF
Virtu Financial
New York
|
-$15K |
| 2 |
XT
XTX Topco
George Town,
Cayman Islands
|
-$2.81K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
-$1.14K |
| 4 |
JP Morgan Chase
New York
|
-$283 |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$125 |
